Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 5OTHER_GOV 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 6Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Mesothelioma, Malignant 3Anus Neoplasms 3Rectal Neoplasms 2Colorectal Neoplasms 2Appendiceal Neoplasms 2Stomach Neoplasms 1Solid Neoplasm 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Necrosis 1HIV Infections 1Gastrointestinal Neoplasms 1Dermatitis 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Anal Canal Carcinoma 1Adenocarcinoma 1

Interventions

Gemcitabine 54Specimen Handling 16Fluorouracil 15Radiotherapy 13Biopsy 12Oxaliplatin 10Magnetic Resonance Spectroscopy 10Erlotinib Hydrochloride 10Cyclophosphamide 10aldesleukin 8fludarabine 7Bevacizumab 7sargramostim 6Radiation 6veliparib 5Trastuzumab 5Leucovorin 5Cetuximab 5Capecitabine 5Taxes 4Sunitinib 4Irinotecan 4HhAntag691 4Cisplatin 42,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 4tipifarnib 3rubitecan 3entinostat 3X-Rays 3Sorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Pancreatic Neoplasms × Mitomycin × Clear all
NCT00005870 2013-12-04

Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas

National Cancer Institute (NCI)

Phase 3 Unknown
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡